T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies

Cancer Immunology, Immunotherapy

Volumn 56, Issue 11, 2007, Pages 1701-1710

  Garrido, Greta ^a,b   Lorenzano, Pablo ^c   Sánchez, Belinda ^a,b   Beausoleil, Irene ^a,b   Alonso, Daniel F ^c   Pérez, Rolando ^a,b   Fernández, Luis E ^a,b  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b Quilmes National University ^*  (Cuba)

^c UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Cancer immunotherapy; EGFR; Metastasis; Monoclonal antibodies; T cell response

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7A7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DRUG EFFECT; DRUG INHIBITION; FEMALE; HISTOPATHOLOGY; LUNG CARCINOMA; LUNG METASTASIS; LYMPHOCYTE DEPLETION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; T-LYMPHOCYTES;

EID: 34548190981     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0313-4     Document Type: Article

References (38)

1. Khazaie K, Schirrmacher V, Lichtner RB (1993) EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12:255-274
2. Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G (1998) Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett 425:145-150
3. O-Charoenrat P, Rhys-Evans P, Modjtahedi H, Court W, Box G, Eccles S (2000) Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 86:307-317
4. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ (1995) Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1:19-31
5. Price JT, Wilson HM, Haites NE (1996) EGF increases in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur J Cancer 32A:1977-1982
6. Salomon D, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183-232
7. Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai K, Zhang Y, Sahai E, Condeelis J, Segall J (2006) EGFR overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 66:192-197
8. Turner T, Chen P, Goodly L, Wells A (1996) EGFR signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis 14:409-418
9. Pal SK, Pegram M (2005) Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy. Anticancer Drugs 16:483-494
10. Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5:257-265
11. Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R (2000) Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 6:1936-1948
12. Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ (1998) Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice. Clin Cancer Res 4:2957-2966
13. Selenko N, Maidic O, Draxier S, Berer A, Jager U, Knapp W, Stockl J (2001) CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells. Leukemia 15:1619-1626
14. Crombet T, Osorio M, Cruz T, Roca C, del Castillo R, Mon R, Iznaga-Escobar N, Figueredo R, Koropatnick J, Renginfo E, Fernandez E, Alvarez D, Torres O, Ramos M, Leonard I, Perez R, Lage A (2004) Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients. J Clin Oncol 22:1646-1654
15. Crombet T, Figueredo J, Catala M, González S, Selva J, Cruz T, Toledo C, Silva S, Pestano5 Y, Ramos1 M, Leonard1 I, Torres1 O, Marinello6 P, Pérez1 R, Lage A (2006) Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3. Cancer Biol Therapy 5:375-379
16. Garrido G, Sánchez B, Rodriguez HM, Menna PL, Alonso D, Fernandez LE (2004) 7A7 MAb: a new tool for the pre-clinical evaluation EGFR-based therapies. Hybrid Hybridomics 23:168-175
17. Vazquez AM, Perez A, Hernandez AM, Macias A, Alfonso M, Bombino G, Perez R (1998) Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybrid Hybridomics 17:527-534
18. Corazzari M, Lovat PE, Oliverio S, Di Sano F, Donnorso RP, Redfern CP, Piacentini M (2005) Fenretinide: a p53-independent way to kill cancer cells. Biochem Biophys Res Commun 331:810-815
19. Eisenbach L, Hollander N, Greenfeld L, Yakor H, Segal S, Feldman M (1984) The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells. Int J Cancer 34:567-573
20. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47:943-946
21. Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF (2001) A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Methods 249:99-110
22. Lasarte JJ, Sarobe P, Prieto J, Borras-Cuesta F (1995) In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes. Res Immunol 146:35
23. Liao J, Yang GY, Park ES, Meng X, Sun Y, Jia D, Seril DN, Yang CS (2004) Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 48:44-53
24. Watanabe T, Kawamura T, Kawamura H, Haga M, Shirai K, Watanabe H, Eguchi S, Abo T (1997) Intermediate TCR cells in mouse lung: their effector function to induce pneumonitis in mice with autoimmune-like graft-versus-host disease. J Immunol 158:5805-5814
25. Mendelsohn J, Baselga J (2003) Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21:2787-2799
26. Janmaat ML, Kruyt FA, Rodriguez JA, Giaccone G (2003) Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways. Clin Cancer Res 9:2316-2326
27. Huang SM, Bock JM, Harari PM (1999) Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 59:1935-1940
28. Yang XD, Wang P, Fredlin P, Davis CG (2002) ABX-EGF, a fully human anti-EGF receptor monoclonal antibody: inhibition of prostate cancer in vitro and in vivo. Proc Am Soc Clin Oncol; Abstract 2454
29. Huang SM, Li J, Harari PM (2002) Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Mol Cancer Ther 1:507-514
30. Naramura M, Gillies SD, Mendelsohn J, Reisfeld RA, Mueller BM (1993) Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma. Cancer Immunol Immunother 37:343-349
31. Bier H, Hoffmann T, Haas I, van Lierop A (1998) Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck. Cancer Immunol Immunother 46:167-173
32. Sánchez B, Suárez E, Garrido G, Hernández T, Pérez R, Ullrich A, Fernández L (2006) Active anti-metastatic immunotherapy in Lewis Lung Carcinoma with self EGFR extra cellular domain protein in VSSP adjuvant. Int J Cancer 119:2190-2199
33. Macluskey M, Baillie R, Chandrachud LM, Pendleton N, Schor AM (2000) High levels of apoptosis are associated with improved survival in non-small cell lung cancer. Anticancer Res 20:2123-2128
34. Cartron G, Watier H, Golay J, Solal-Celigny P (2004) From the bench to the bedside: ways to improve rituximab efficacy. Blood 104:2635-2639
35. Restifo N (2000) Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptative immunity. Curr Opin Immunol 12:597-603
36. Lake RA, Robinson BWS (2005) Immunotherapy and chemotherapy-a practical partnership. Nat Rev 5:397-405
37. Fen H, Zeng Y, Graner MW, Katsanis E (2002) Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100:4108-4115
38. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-521